Interferon-γ exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways.
about
Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis siccaAging: a predisposition to dry eyes.Dry eye as a mucosal autoimmune disease.Antibody to mCLCA3 suppresses symptoms in a mouse model of asthma.Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture.Topical fluorometholone treatment for ocular dryness in patients with Sjögren syndrome: a randomized clinical trial in ChinaConjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines.Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren SyndromeInflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model.Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice.Therapeutic Efficacy of Topically Applied Antioxidant Medicinal Plant Extracts in a Mouse Model of Experimental Dry Eye.Interferon-γ-Induced Unfolded Protein Response in Conjunctival Goblet Cells as a Cause of Mucin Deficiency in Sjögren Syndrome.Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.T helper cytokines in dry eye diseaseTopical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eyeOcular surface disease and dacryoadenitis in aging C57BL/6 mice.Interferon-gamma deficiency protects against aging-related goblet cell loss.Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells.Towards a dynamic customised therapy for ocular surface dysfunctions.Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca.Comparison of 0.3% Hypotonic and Isotonic Sodium Hyaluronate Eye Drops in the Treatment of Experimental Dry Eye.Ageing and ocular surface immunity.Mucosal immune tolerance at the ocular surface in health and disease.High levels of β-catenin promote IFNγ-induced apoptosis in hepatocellular carcinoma cells.Dry Eye Management: Targeting the Ocular Surface Microenvironment.Interaction of IFN-γ with cholinergic agonists to modulate rat and human goblet cell function.Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival.Caspase protocols in mice.The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.Sjögren-Like Lacrimal Keratoconjunctivitis in Germ-Free Mice.Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye DiseaseComparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye
P2860
Q34028408-6D6229A7-EC7A-413D-9B56-9E1A98A0D200Q34110644-CBA1CCA4-3418-41DC-9F1D-6CB16A162099Q34114336-659D554B-768A-4AD5-8916-03B35561DF95Q34647761-4CE31E75-0291-4412-A670-1129E53A537BQ35070224-DEDC52D1-291C-47D3-80B1-40CE0D1E8BD0Q35356313-29ABBE96-AF33-4A2D-B2D5-37B6867C19EEQ35570793-DA570AB8-6283-44F1-8816-8B745DB0929AQ36009560-D8DD0A5B-BD86-423D-BF1E-331C6E1EDA4EQ36300034-280B39CB-390A-47F2-85A0-5D6132912192Q36806556-389BB4C6-F560-48E1-8FD2-4718470A567AQ36872927-BF6B610D-DB0A-4EC4-A7E8-177498228E35Q36907644-2375D913-42E5-46D8-9D2A-C84A074876D2Q36985541-A6C3B035-395E-485D-9D13-74673DD7CF07Q36990222-DC443993-0595-4A16-A256-EAFD5FA4BED5Q37050342-0D37A13F-88C6-4271-AD29-C930FE18B61FQ37374838-1F21944C-1D1C-46D9-A23C-53FC77639FBDQ37513125-834CEAED-4A0B-4608-BC4D-E43DAAF408F4Q37605983-30C8690C-0647-4EAA-ABEE-E872091362B2Q37662097-B5BB442C-0A1E-4CD1-A41F-237437B48644Q37737497-5983672C-CF8E-4CD0-8C82-DF0A94C9F704Q38098900-020F0236-F69A-48FC-BF80-4C1E055E1AA2Q38176265-FA6086EA-ED54-4228-A63A-DAC83723479DQ38820903-9D0F358F-F50E-4307-B5B7-F8FDE8176363Q38886086-1E418202-C516-4E1B-A4FE-FB05DCC37181Q39097223-67C3ED76-8ABF-4C1F-BC35-00A1EC2423C2Q39242767-881675A8-7B75-40AC-87ED-3095EBC40D32Q39404635-9F9B4486-BED0-4C34-81B4-6A922DAD7534Q41386825-E2A1BFB0-BFAA-4EED-A781-7BD3CF101A1CQ41903427-B5D184E4-7D15-46E1-8130-36295C344EBBQ42008487-8F357D80-A9AC-434B-8360-4509E2832BC8Q47884949-8CA63FE3-69A0-4ADB-AA27-40E0D976BA8DQ50041932-1BF84835-86FE-4569-BEE6-D9ED282F446CQ57479273-826667E3-0C5C-483F-830E-C2481440A101Q58771513-2D6E02BC-22C8-4D29-81BC-1400CD5EB148
P2860
Interferon-γ exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interferon-γ exacerbates dry e ...... rough dual apoptotic pathways.
@ast
Interferon-γ exacerbates dry e ...... rough dual apoptotic pathways.
@en
type
label
Interferon-γ exacerbates dry e ...... rough dual apoptotic pathways.
@ast
Interferon-γ exacerbates dry e ...... rough dual apoptotic pathways.
@en
prefLabel
Interferon-γ exacerbates dry e ...... rough dual apoptotic pathways.
@ast
Interferon-γ exacerbates dry e ...... rough dual apoptotic pathways.
@en
P2093
P2860
P356
P1476
Interferon-γ exacerbates dry e ...... hrough dual apoptotic pathways
@en
P2093
Andrew J McClellan
De-Quan Li
Eugene A Volpe
Rosa M Corrales
Stephen C Pflugfelder
William J Farley
Xiaobo Zhang
P2860
P304
P356
10.1167/IOVS.10-7081
P407
P577
2011-08-09T00:00:00Z